Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 6/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.62 |
| ▸ | P4HTM | Q9NXG6 | 2/20 | 0.62 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.61 |
| ▸ | CCR1 | P32246 | 2/20 | 0.61 |
| ▸ | CCR5 | P51681 | 2/20 | 0.61 |
| ▸ | CCR8 | P51685 | 2/20 | 0.61 |
| ▸ | TP53 | P04637 | 2/20 | 0.61 |
| ▸ | HTT | P42858 | 2/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.61 |
| ▸ | ALPL | P05186 | 1/20 | 0.61 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.61 |
| ▸ | ALPI | P09923 | 1/20 | 0.61 |
| ▸ | ALPG | P10696 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1456823 | 0.93 | KDM4E (0.58) | LMNAL3MBTL1P4HTMNAPRTKDM4E | |
| SCHEMBL20401669 | 0.88 | L3MBTL1 (0.49) | LMNAL3MBTL1P4HTMNAPRTKDM4E | |
| SCHEMBL29357675 | 0.86 | KDM4E (0.76) | LMNAL3MBTL1P4HTMNAPRTKDM4E | |
| SCHEMBL70765 | 0.86 | KDM4E (0.76) | LMNAL3MBTL1P4HTMNAPRTKDM4E | |
| SCHEMBL17489130 | 0.86 | LMNA (0.50) | LMNAL3MBTL1P4HTMNAPRTKDM4E | |
| SCHEMBL20412771 | 0.86 | KMT2A (0.68) | LMNAL3MBTL1P4HTMNAPRTKDM4E | |
| SCHEMBL29355234 | 0.84 | KDM4E (0.73) | LMNAL3MBTL1P4HTMNAPRTKDM4E | |
| SCHEMBL143651 | 0.84 | KDM4E (0.73) | LMNAL3MBTL1P4HTMNAPRTKDM4E | |
| SCHEMBL935065 | 0.84 | KDM4E (0.59) | LMNAL3MBTL1P4HTMNAPRTKDM4E | |
| SCHEMBL3165743 | 0.84 | ALDH1A1 (0.63) | LMNAL3MBTL1P4HTMNAPRTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250362307-A1 | PHOTOACTIVE ANTIBODY CONJUGATE | LIAO JUNG CHI (TW) | 2025-11-27 | — | — | US | claimed |
| EP-4473309-A1 | PHOTOACTIVE ANTIBODY CONJUGATE | Syncell (Taiwan) Inc. (TW) | 2024-12-11 | — | — | EP | claimed |
| CN-117142938-A | Method for preparing 1, 4-naphthoquinone compound by selectively oxidizing aromatic ketone | 大连理工大学 | 2023-12-01 | — | — | CN | claimed |
| CN-117026295-A | COF composite material and preparation method and application thereof | 深圳技术大学 | 2023-11-10 | — | — | CN | claimed |
| WO-2023196986-A1 | PHOTOACTIVE ANTIBODY CONJUGATE | Syncell (Taiwan) Inc. (TW) | 2023-10-12 | — | — | WO | claimed |
| CN-113559939-B | Alpha alkylation reaction catalyst of nitrile and preparation method thereof | 郑州大学 | 2023-06-23 | — | — | CN | claimed |
| CN-113559939-A | Alpha alkylation reaction catalyst for nitrile and preparation method thereof | 郑州大学 | 2021-10-29 | — | — | CN | claimed |
| CN-111440174-B | Pyridine amide compound and preparation method and application thereof | 广州医科大学 | 2021-07-09 | — | — | CN | claimed |
| CN-109970814-A | Pincerlike ruthenium compound of the asymmetric NNN ' containing pyridine-pyridine-imidazoline and preparation method thereof | 郑州大学 | 2019-07-05 | — | — | CN | claimed |
| US-20250362307-A1 | PHOTOACTIVE ANTIBODY CONJUGATE | LIAO JUNG CHI (TW) | 2025-11-27 | — | — | US | disclosed |
| EP-4473309-A1 | PHOTOACTIVE ANTIBODY CONJUGATE | Syncell (Taiwan) Inc. (TW) | 2024-12-11 | — | — | EP | disclosed |
| CN-118029974-A | Steam injection catalytic modification coking sand prevention method and catalyst for loose sandstone heavy oil reservoir | 中国石油化工股份有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-117751124-A | Spiro oxindole compounds and application thereof in preparing antiviral protease inhibitor medicines | 南京药石科技股份有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117377668-A | Inhalant formulations of PGDH inhibitors and methods of use thereof | 迈欧伏特治疗公司 | 2024-01-09 | — | — | CN | disclosed |
| CN-101223141-A | Certain substituted amides, method of making, and method of use thereof | CGI PHARMACEUTICALS INC (US) | 2008-07-16 | — | — | CN | disclosed |
| EP-1742936-A2 | POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS | Icagen, Inc. (US) | 2007-01-17 | — | — | EP | disclosed |
| EP-1644372-A2 | SUBSTITUTED QUINOLIN-4-YLAMINE ANALOGUES | NEUROGEN CORPORATION (US) | 2006-04-12 | — | — | EP | disclosed |
| WO-2005100340-A2 | POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS | ICAGEN, INC. (US) | 2005-10-27 | — | — | WO | disclosed |
| US-20050227958-A1 | Polycyclic pyridines as potassium ion channel modulators | ICAGEN, INC. (US) | 2005-10-13 | — | — | US | disclosed |
| WO-2005007652-A2 | SUBSTITUTED QUINOLIN-4-YLAMINE ANALOGUES | NEUROGEN CORPORATION (US) | 2005-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050227958-A1 | Polycyclic pyridines as potassium ion channel modulators | KCNJ2, KCNH2, KCNQ1 | LMNA 3338/4885L3MBTL1 3704/4885P4HTM 624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.